Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06663098
Title Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC). (CARRY-ON)
Acronym CARRY-ON
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gruppo Oncologico Italiano di Ricerca Clinica
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.